Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP320062.RAdnavf1psTP4-jTjBZQCW0gB8yT_6l8wdBRwiJliRsPg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP320062.RAdnavf1psTP4-jTjBZQCW0gB8yT_6l8wdBRwiJliRsPg130_assertion type Assertion NP320062.RAdnavf1psTP4-jTjBZQCW0gB8yT_6l8wdBRwiJliRsPg130_head.
- NP320062.RAdnavf1psTP4-jTjBZQCW0gB8yT_6l8wdBRwiJliRsPg130_assertion description "[Adel55-cHSF1 treatment also showed higher efficacy in diminishing progression of the secondary tumor focus than Adel55-HSP70 or Adel55-HSP90 treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP320062.RAdnavf1psTP4-jTjBZQCW0gB8yT_6l8wdBRwiJliRsPg130_provenance.
- NP320062.RAdnavf1psTP4-jTjBZQCW0gB8yT_6l8wdBRwiJliRsPg130_assertion evidence source_evidence_literature NP320062.RAdnavf1psTP4-jTjBZQCW0gB8yT_6l8wdBRwiJliRsPg130_provenance.
- NP320062.RAdnavf1psTP4-jTjBZQCW0gB8yT_6l8wdBRwiJliRsPg130_assertion SIO_000772 22613625 NP320062.RAdnavf1psTP4-jTjBZQCW0gB8yT_6l8wdBRwiJliRsPg130_provenance.
- NP320062.RAdnavf1psTP4-jTjBZQCW0gB8yT_6l8wdBRwiJliRsPg130_assertion wasDerivedFrom befree-20140225 NP320062.RAdnavf1psTP4-jTjBZQCW0gB8yT_6l8wdBRwiJliRsPg130_provenance.
- NP320062.RAdnavf1psTP4-jTjBZQCW0gB8yT_6l8wdBRwiJliRsPg130_assertion wasGeneratedBy ECO_0000203 NP320062.RAdnavf1psTP4-jTjBZQCW0gB8yT_6l8wdBRwiJliRsPg130_provenance.